Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Gammopathy of Unknown Significance”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01045772
What this trial is testing

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

Who this might be right for
Muckle-Wells SyndromeSchnitzler Syndrome
Charite University, Berlin, Germany 10
Not applicableActive Not RecruitingNCT04920084
What this trial is testing

A Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center 23
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850846
What this trial is testing

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 60
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT03629561
What this trial is testing

Diagnosis of MGRS in Patients With Paraproteinemias: Clinical, Anatomopathological and Pathophysiological Study

Who this might be right for
Monoclonal Gammopathy of Renal Significance
Academia Nacional de Medicina 15
Not applicableActive Not RecruitingNCT04023747
What this trial is testing

Oxford Pre-cancerous Lymphoproliferative Disorders Study

Who this might be right for
Pre-cancerous Lymphoproliferative Disorders
University of Oxford 574
Not applicableStudy completedNCT00900263
What this trial is testing

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

Who this might be right for
Multiple MyelomaPlasma Cell MyelomaPrecancerous Condition
SWOG Cancer Research Network 375
Not applicableStudy completedNCT06559579
What this trial is testing

Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)

Who this might be right for
Gammopathy, Monoclonal
University Hospital, Brest 80
Not applicableStudy completedNCT00898066
What this trial is testing

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous/Nonmalignant Condition
SWOG Cancer Research Network 37
Testing effectiveness (Phase 2)UnknownNCT05114109
What this trial is testing

Isatuximab in Type I Cryoglobulinemia

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceCryoglobulinemic Vasculitis
Assistance Publique - Hôpitaux de Paris 21
Not applicableEnrolling By InvitationNCT07057583
What this trial is testing

Carbon 13-based Deep Labelling of Bone Marrow Cells

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Non-IgM Monoclonal Gammopathy of Undetermined Significance
Mayo Clinic 40
Not applicableLooking for participantsNCT03616483
What this trial is testing

The Indiana Myeloma Registry

Who this might be right for
Plasma Cell Dyscrasias
Indiana University 2,500
Not applicableEnded earlyNCT00062231
What this trial is testing

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more
European Organisation for Research and Treatment of Cancer - EORTC 351
Testing effectiveness (Phase 2)WithdrawnNCT01571726
What this trial is testing

Imaging Studies and the Development of Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00099047
What this trial is testing

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 23
Not applicableActive Not RecruitingNCT07214324
What this trial is testing

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 60
Testing effectiveness (Phase 2)Ended earlyNCT00588822
What this trial is testing

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

Who this might be right for
Precancerous Condition
Mayo Clinic 21
Load More Results